2TG Stock Overview Provides infection prevention products and services worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for STERIS Historical stock prices Current Share Price US$173.42 52 Week High US$232.90 52 Week Low US$166.46 Beta 0.81 1 Month Change 0% 3 Month Change 0.50% 1 Year Change -15.65% 3 Year Change 29.42% 5 Year Change n/a Change since IPO 542.30%
Recent News & Updates STERIS plc, Annual General Meeting, Aug 01, 2024 Jun 15
STERIS plc Provides Earnings Guidance for the Fiscal Year 2025 May 10
STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024 May 02
STERIS plc to Report Q4, 2024 Results on May 08, 2024 Apr 26
STERIS plc Revises Financial Guidance for the Fiscal Year 2024 Feb 08
STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024 Jan 31 See more updates STERIS plc, Annual General Meeting, Aug 01, 2024 Jun 15
STERIS plc Provides Earnings Guidance for the Fiscal Year 2025 May 10
STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024 May 02
STERIS plc to Report Q4, 2024 Results on May 08, 2024 Apr 26
STERIS plc Revises Financial Guidance for the Fiscal Year 2024 Feb 08
STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024 Jan 31
STERIS plc to Report Q3, 2024 Results on Feb 07, 2024 Jan 24
STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024 Nov 10
STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024 Nov 09
STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023 Nov 01
STERIS plc to Report Q2, 2024 Results on Nov 07, 2023 Oct 25
STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board Jul 29
STERIS plc to Report Q1, 2024 Results on Aug 01, 2023 Jul 22
STERIS plc, Annual General Meeting, Jul 27, 2023 Jun 09
STERIS plc Provides Revenue Guidance for the Fiscal Year 2024 May 12 STERIS plc (NYSE:STE) announces an Equity Buyback for $500 million worth of its shares.
STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023 Feb 09
STERIS plc Declares Quarterly Interim Dividend, Payable on March 23, 2023 Feb 02
STERIS plc to Report Q3, 2023 Results on Feb 08, 2023 Jan 26
STERIS plc Revises Earnings Guidance for the Fiscal Year 2023 Nov 12
STERIS plc Declares Interim Dividend, Payable on December 16, 2022 Nov 03
STERIS plc to Report Q2, 2023 Results on Nov 09, 2022 Oct 26
Upcoming dividend of US$0.47 per share Aug 30
First quarter 2023 earnings released: EPS: US$1.11 (vs US$0.24 loss in 1Q 2022) Aug 03
STERIS plc Provides Revenue Guidance for Fiscal 2023 Aug 03
Steris plc Declares Quarterly Interim Dividend, Payable on September 23, 2022 Jul 29
STERIS plc to Report Q1, 2023 Results on Aug 02, 2022 Jul 21
STERIS plc(NYSE:STE) dropped from Russell 1000 Growth-Defensive Index Jun 26 STERIS plc, Annual General Meeting, Jul 28, 2022 Jun 08
Upcoming dividend of US$0.43 per share Jun 06
Full year 2022 earnings released: EPS: US$2.50 (vs US$4.66 in FY 2021) May 13
STERIS plc Provides Earnings Guidance for Fiscal 2023 May 12
Steris plc Declares Quarterly Interim Dividend, Payable on June 28, 2022 May 05
STERIS plc to Report Q4, 2022 Results on May 11, 2022 Apr 26
Upcoming dividend of US$0.43 per share Feb 17
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 09
STERIS plc Raises Earnings Guidance for the Fiscal Year 2022 Feb 09
STERIS plc Declares Quarterly Interim Dividend, Payable March 24, 2022 Feb 01
Insider recently sold €398k worth of stock Nov 18
Upcoming dividend of US$0.43 per share Nov 15
Second quarter 2022 earnings released: EPS US$0.70 (vs US$1.24 in 2Q 2021) Nov 03
Upcoming dividend of US$0.43 per share Aug 26
Insider recently sold €2.0m worth of stock Aug 18
STERIS plc Provides Earnings Guidance for the Year 2022 Aug 12
First quarter 2022 earnings released: US$0.24 loss per share (vs US$1.04 profit in 1Q 2021) Aug 10
Independent Director David Lewis has left the company Aug 04
STERIS plc (NYSE:STE) completed the acquisition of Cantel Medical Corp. (NYSE:CMD) from Charles M. Diker, Mark N. Diker, Diker Management LLC, Champlain Investment Partners, LLC, Brown Capital Management, LLC and others. Jun 03
Full year 2021 earnings released: EPS US$4.66 (vs US$4.81 in FY 2020) May 20 STERIS plc Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022
STERIS plc Provides Earnings Guidance for the Fiscal 2021 Apr 28
New 90-day low: €147 Feb 23 STERIS Announces Leadership Succession Plan
Third quarter 2021 earnings released: EPS US$1.34 (vs US$1.24 in 3Q 2020) Feb 03
Revenue beats expectations Feb 03
STERIS plc (NYSE:STE) signed a definitive agreement to acquire Cantel Medical Corp. (NYSE:CMD) for $3.6 billion. Jan 13
STERIS plc to Report Q3, 2021 Results on Feb 02, 2021 Jan 08
CEO, President & Director recently sold €1.5m worth of stock Nov 11
Revenue beats expectations Nov 05
Second quarter 2021 earnings released: EPS US$1.24 Nov 05
STERIS plc to Report Q2, 2021 Results on Nov 02, 2020 Oct 07 Shareholder Returns 2TG DE Medical Equipment DE Market 7D 0% -2.3% -1.4% 1Y -15.7% -6.9% 8.0%
See full shareholder returns
Return vs Market: 2TG underperformed the German Market which returned 5.9% over the past year.
Price Volatility Is 2TG's price volatile compared to industry and market? 2TG volatility 2TG Average Weekly Movement n/a Medical Equipment Industry Average Movement 6.7% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.9% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: 2TG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2TG's volatility change over the past year.
About the Company STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Show more STERIS plc Fundamentals Summary How do STERIS's earnings and revenue compare to its market cap? 2TG fundamental statistics Market cap €17.98b Earnings (TTM ) -€7.65m Revenue (TTM ) €4.49b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 2TG income statement (TTM ) Revenue US$4.78b Cost of Revenue US$2.70b Gross Profit US$2.08b Other Expenses US$2.09b Earnings -US$8.14m
Last Reported Earnings
Sep 30, 2022
Earnings per share (EPS) -0.082 Gross Margin 43.49% Net Profit Margin -0.17% Debt/Equity Ratio 52.0%
How did 2TG perform over the long term?
See historical performance and comparison Dividends
1.0% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2023/01/09 08:36 End of Day Share Price 2022/10/12 00:00 Earnings 2022/09/30 Annual Earnings 2022/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources STERIS plc is covered by 25 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Daniel Owczarski Avondale Partners Michael Polark Baird Erin Wilson Wright BofA Global Research
Show 22 more analysts 
